Hub di presentazione

Hub di presentazione

Benvenuti nell’hub presentazioni, dove è possibile creare, modificare, salvare ed esportare presentazioni personalizzate scegliendo dalla nostra gamma di presentazioni didattiche.

Immetti almeno 3 caratteri
Featured
PIÙ RECENTI

Contenuto consigliato

COVID-19 and its implications in heart failure
PRESENTAZIONE
COVID-19 and its implications in heart failure
Visualizza contenuto
Can new-onset diabetes be prevented
PRESENTAZIONE
Can new-onset diabetes be prevented
Visualizza contenuto
Practicalities of SGLT2 inhibition – pros vs cons
Infografica
Practicalities of SGLT2 inhibition – pros vs cons
Visualizza contenuto
Updates on ESC heart failure guidelines
Video
Updates on ESC heart failure guidelines
Visualizza contenuto
Cardiologist Practical Guide to Prescribing
Infografica
Cardiologist Practical Guide to Prescribing
Visualizza contenuto
Cardiovascular
PIÙ RECENTI

Cardiovascolare

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
PRESENTAZIONE
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Visualizza contenuto
What did the study tell us about the safety of medicines in heart failure?
PRESENTAZIONE
What did the study tell us about the safety of medicines in heart failure?
Visualizza contenuto
Hiding in plain sight – how to detect heart failure in primary care
PRESENTAZIONE
Hiding in plain sight – how to detect heart failure in primary care
Visualizza contenuto
Optimizing HF discharge care and follow-up
PRESENTAZIONE
Optimizing HF discharge care and follow-up
Visualizza contenuto
Visualizza tutte le presentazioni Cardiovascolare
Infection and Vaccines
PIÙ RECENTI

Infezioni e vaccini

Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
PRESENTAZIONE
Mechanisms behind the cardiovascular benefits of SGLT2 inhibitors
Visualizza contenuto
What did the study tell us about the safety of medicines in heart failure?
PRESENTAZIONE
What did the study tell us about the safety of medicines in heart failure?
Visualizza contenuto
Optimizing HF discharge care and follow-up
PRESENTAZIONE
Optimizing HF discharge care and follow-up
Visualizza contenuto
Kidney outcomes associated with inhibition of SGLT2
PRESENTAZIONE
Kidney outcomes associated with inhibition of SGLT2
Visualizza contenuto
Visualizza tutte le presentazioni Infezioni e vaccini
Metabolic
PIÙ RECENTI

Metabolico

Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
PRESENTAZIONE
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Visualizza contenuto
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
PRESENTAZIONE
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Visualizza contenuto
Clinical recommendations for the management of type 2 diabetes
PRESENTAZIONE
Clinical recommendations for the management of type 2 diabetes
Visualizza contenuto
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRESENTAZIONE
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Visualizza contenuto
Visualizza tutte le presentazioni Metabolico
Oncology
PIÙ RECENTI

Oncologia

Optimizing HF discharge care and follow-up
PRESENTAZIONE
Optimizing HF discharge care and follow-up
Visualizza contenuto
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
PRESENTAZIONE
Managing Type 2 Diabetes Beyond Glycemia : Cardiorenal risk in T2D
Visualizza contenuto
Clinical recommendations for the management of type 2 diabetes
PRESENTAZIONE
Clinical recommendations for the management of type 2 diabetes
Visualizza contenuto
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
PRESENTAZIONE
Managing type 2 diabetes beyond glycemia: cardiorenal risk in T2D
Visualizza contenuto
Visualizza tutte le presentazioni Oncologia
Renal
PIÙ RECENTI

Funzionalità renale

Chronic kidney disease management
PRESENTAZIONE
Chronic kidney disease management
Visualizza contenuto
Renal protection with SGLT2 inhibitors: what every cardiologist should know
PRESENTAZIONE
Renal protection with SGLT2 inhibitors: what every cardiologist should know
Visualizza contenuto
Kidney outcomes associated with inhibition of SGLT2
PRESENTAZIONE
Kidney outcomes associated with inhibition of SGLT2
Visualizza contenuto
Medicines in chronic kidney disease
PRESENTAZIONE
Medicines in chronic kidney disease
Visualizza contenuto
Visualizza tutte le presentazioni Funzionalità renale
Respiratory and Immunology
PIÙ RECENTI

Respiratorio e immunologico

The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
PRESENTAZIONE
The benefits of SGLT2 inhibitors in type-2 diabetes, chronic kidney disease and heart failure
Visualizza contenuto
Clinical recommendations for the management of type 2 diabetes
PRESENTAZIONE
Clinical recommendations for the management of type 2 diabetes
Visualizza contenuto
Chronic kidney disease management
PRESENTAZIONE
Chronic kidney disease management
Visualizza contenuto
Medicines in chronic kidney disease
PRESENTAZIONE
Medicines in chronic kidney disease
Visualizza contenuto
Visualizza tutte le presentazioni Respiratorio e immunologico
Rare Disease
PIÙ RECENTI

Malattia rara

What did the study tell us about the safety of medicines in heart failure?
PRESENTAZIONE
What did the study tell us about the safety of medicines in heart failure?
Visualizza contenuto
Hiding in plain sight – how to detect heart failure in primary care
PRESENTAZIONE
Hiding in plain sight – how to detect heart failure in primary care
Visualizza contenuto
Chronic kidney disease management
PRESENTAZIONE
Chronic kidney disease management
Visualizza contenuto
Medicines in chronic kidney disease
PRESENTAZIONE
Medicines in chronic kidney disease
Visualizza contenuto
Visualizza tutte le presentazioni Malattia rara
In primo piano
PIÙ RECENTI

Contenuti di tendenza

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
PRESENTAZIONE
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
Visualizza contenuto
Cardiologist Practical Guide to Prescribing
Infografica
Cardiologist Practical Guide to Prescribing
Visualizza contenuto
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
Video
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
Visualizza contenuto
Cardiorenal benefits of SGLT2 inhibitors
PRESENTAZIONE
Cardiorenal benefits of SGLT2 inhibitors
Visualizza contenuto
Diagnosis and co-morbidities of chronic kidney disease
Video
Diagnosis and co-morbidities of chronic kidney disease
Visualizza contenuto